Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

NCT07337967 is registered in ClinicalTrials.gov with Huda Ahmed Abdelsabour Abdelwahab as lead sponsor.

NCT NCT07337967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07337967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms
Lead sponsor
Huda Ahmed Abdelsabour Abdelwahab
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
September 1, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

b chronic lymphocytic leukemia